SUHEUNG CO.,LTD. Logo

SUHEUNG CO.,LTD.

Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.

008490 | KO

Overview

Corporate Details

ISIN(s):
KR7008490005
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명로 61 -, 청주시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Suheung Co., Ltd. is a global manufacturer specializing in capsules for the pharmaceutical and nutraceutical industries. Established in 1973, the company produces a wide range of empty hard and soft capsules, as well as other solid dosage forms like tablets. Suheung is a vertically integrated enterprise, offering comprehensive contract manufacturing services that cover the entire process from raw material supply to final packaging. As one of the largest capsule suppliers worldwide, the company serves major global markets, emphasizing quality and continuous research and development to deliver solutions for its clients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 83.3 KB
2025-08-14 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 5.1 MB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 5.0 MB
2025-05-30 00:00
Governance Information
기업지배구조보고서공시
Korean 1.0 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 3.0 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 712.2 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 20.8 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 17.8 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 62.1 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.1 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 373.7 KB
2025-02-27 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.4 KB
2025-02-18 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 13.9 KB
2025-02-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.5 KB

Automate Your Workflow. Get a real-time feed of all SUHEUNG CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SUHEUNG CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SUHEUNG CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NEOGEN CORP Logo
Provides diagnostic tests and genomics services for food, animal, and agricultural safety.
United States of America
NEOG
NEOGENOMICS INC Logo
Provides precision oncology testing for cancer diagnostics, therapy guidance, and research.
United States of America
NEO
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America
950220
NEONC TECHNOLOGIES HOLDINGS, INC. Logo
Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.
United States of America
NTHI
Neumora Therapeutics, Inc. Logo
Developing data-driven precision medicines for neuropsychiatric and neurodegenerative disorders.
United States of America
NMRA
Neuphoria Therapeutics Inc. Logo
Develops novel ion channel modulators for treating neuropsychiatric disorders like anxiety & PTSD.
United States of America
NEUP
NEUROCRINE BIOSCIENCES INC Logo
Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.
United States of America
NBIX
Neurogene Inc. Logo
Developing genetic medicines using gene therapy for rare and devastating neurological diseases.
United States of America
NGNE
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America
NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America
NAMS

Talk to a Data Expert

Have a question? We'll get back to you promptly.